Lv41
560 积分 2024-03-26 加入
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
2小时前
已完结
Clinical features, diagnosis and prognosis of nivolumab-associated fulminant type 1 diabetes
2个月前
已完结
Familial Hypercholesterolemia: Update and Review
3个月前
已完结
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
6个月前
已完结
Immunotherapy: Building a bridge to a cure for type 1 diabetes
9个月前
已完结
Immune-Related Adverse Events of Immune Checkpoint Inhibitors
1年前
已完结
程序性死亡受体1抑制剂相关1型糖尿病的临床特点分析
1年前
已完结
皖公网安备34019202002308
